drug delivery across the skin is used for several millennia to ease gastrointestinal (gi) ailments in traditional persian medicine (tpm). tpm topical remedies are generally being applied on the stomach, lower abdomen, lower back and liver to alleviate gi illnesses such as dyspepsia, gastritis, gi ulcers, inflammatory bowel disease, intestinal worms and infections. the aim of the present study i...

Patients with chronic kidney disease (CKD) constitute a population at high risk for adverse drug reactions and/or drug-drug interactions. Renal dysfunction-induced pathophysiological changes may alter both medication pharmacodynamics and handling. Most pharmacokinetic parameters are adversely affected by impaired kidney function, among which reduced glomerular filtration and altered tubular sec...

Treatment-resistant depression is extremely common-but does that mean there is no place for antidepressants?

Numerous mandibular pathologies are diagnosed in the emergency department (ED). We present the case of a woman with severe right-sided mandibular pain who was found to have a pathological fracture and osteonecrosis of the jaw (ONJ). The etiology of ONJ was found to be associated to previous use of zoledronic acid to treat osteoporosis. The aim of this case report is to discuss the etiology, dia...

Although Circulation is primarily a repository for original papers, one's resolve to keep it pure is repeatedly eroded by the claim of mundane problems of practice to attention in its pages. In the terminology of Fox,1 one's goal is to have a pure "recorder" joumal but, occasionally, "newspaper" objectives have claims to space that are difficult to deny. I wish to draw the attention of speciali...

The use of medications as an adjunct to alcoholism treatment is based on the premise that craving and other manifestations of alcoholism are mediated by neurobiological mechanisms. Three of the four medications approved in the United States or Europe for treating alcoholism are reported to reduce craving; these include naltrexone (ReVia), acamprosate, and tiapride. The remaining medication, dis...

The timely article by Verdoux & Begaud ́ hopefully begins to redress the imbalance between randomised controlled trials and other ways of evaluating drug treatments. I would like to present further evidence for the ‘gap between guidelines and utilisation . . . for psychotropic medications’ (Verdoux & Begaud, 2004). ́ Using the Drug Report of the German Public Health Insurance (Schwabe & Pfaffrath...

Lawrence DeMarzo: My agency, House of the Crossroads, like other drug-free com­ munity-based agencies, has historically cho­ sen not to use medications in its treatment regimens. That is changing now, through our involvement in NIDA’s Clinical Trials Network and our acquaintance with litera­ ture like Dr. Kampman’s article (Kampman, 2008). Much has changed since we started Cross­ roads. We know...

Spasticity is common in patients with a variety of central nervous system disorders. It can lead to significant disability or cause complications that may result in severe morbidity. In such patients, treatment of spasticity is warranted. Several oral and parenteral medications are available for use in the treatment of spasticity. This article reviews the pharmacological properties and therapeu...